The project constitutes a collaboration between Malcisbo and the following academic partners: Department of Swine Medicine, University of Zurich; Institute of Bacteriology, University of Berne; Institute of Virology and Immunology, Berne (IVI); Federal Technical University Zurich (ETH). Within this project immunogenicity and protection of Malcisbo`s novel carbohydrate-based APP vaccine will be evaluated.

Link to CTI R&D grants